Literature DB >> 34150143

The effect of electronic moxibustion combined with rehabilitation nursing on the lumbar pain and stiffness of ankylosing spondylitis patients.

Xin Huan1, Liugeng Wu1, Meiyi Wang1, Danping Xue2, Feng Tian1.   

Abstract

OBJECTIVE: To investigate the effect of electronic moxibustion combined with rehabilitation nursing on the lumbar pain and stiffness of ankylosing spondylitis patients.
METHODS: Ninety-four ankylosing spondylitis patients were recruited as the study cohort and randomly assigned into a control group, which underwent rehabilitation nursing, and a research group, which underwent electronic moxibustion combined with rehabilitation nursing. The clinical effects in the two groups were compared, and the occipital-wall distances, finger-floor distances, spine mobility, morning stiffness durations, overall morning stiffness levels, lower back pain, motor performance of the upper and lower limbs, and the quality of life were compared between the two groups before and after the intervention.
RESULTS: The effective rate in the research group was significantly higher than it was in the control group (91.49% vs. 74.47%, P < 0.001). The research group patients had significantly greater occipital-wall distances, better spine mobility and shorter finger-floor distances than the control group after the intervention (all P < 0.05). The research group patients also showed significantly shorter morning stiffness durations, lower overall morning stiffness levels, and the lower visual analogue scale (VAS) lower back scores than the control group (all P < 0.05). The motor performance of the upper and lower limbs in the research group was significantly better than it was in the control group after the intervention (P < 0.05). The research group had significantly higher quality of life scores than the control group (all P < 0.05).
CONCLUSION: Electronic moxibustion combined with rehabilitation nursing in ankylosing spondylitis patients shows significant advantages compared with rehabilitation nursing alone. The combination, which can improve the quality of life, and the motor performance of the upper and lower limbs, and relieve patients' lumbar pain and stiffness, is worthy of further promotion and application. AJTR
Copyright © 2021.

Entities:  

Keywords:  Morning stiffness duration; ankylosing spondylitis; electronic moxibustion; motor performance; rehabilitation nursing

Year:  2021        PMID: 34150143      PMCID: PMC8205716     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  20 in total

1.  Varicella Zoster and Cutaneous Candida Infection in a Patient With Ankylosing Spondylitis Under Treatment With Secukinumab.

Authors:  Ali Nail Demİr; İsmail UÇar; Cahit KaÇar
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

2.  Association of Long Noncoding RNAs Polymorphisms With Ankylosing Spondylitis, Vogt-Koyanagi-Harada Disease, and Behcet's Disease.

Authors:  Yingying Yue; Jun Zhang; Lu Yang; Shengyun Liu; Jian Qi; Qingfeng Cao; Chunjiang Zhou; Yao Wang; Aize Kijlstra; Peizeng Yang; Shengping Hou
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

3.  Comparative Efficacy of Tumor Necrosis Factor-α Inhibitors in Ankylosing Spondylitis: A Systematic Review and Bayesian Network Metaanalysis.

Authors:  Runsheng Wang; Abhijit Dasgupta; Michael M Ward
Journal:  J Rheumatol       Date:  2018-01-15       Impact factor: 4.666

4.  TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.

Authors:  Christoph Molnar; Almut Scherer; Xenofon Baraliakos; Manouk de Hooge; Raphael Micheroli; Pascale Exer; Rudolf O Kissling; Giorgio Tamborrini; Lukas M Wildi; Michael J Nissen; Pascal Zufferey; Jürg Bernhard; Ulrich Weber; Robert B M Landewé; Désirée van der Heijde; Adrian Ciurea
Journal:  Ann Rheum Dis       Date:  2017-09-22       Impact factor: 19.103

5.  Association between tonsillitis and newly diagnosed ankylosing spondylitis: A nationwide, population-based, case-control study.

Authors:  Wen-Cheng Chao; Ching-Heng Lin; Yi-Ming Chen; Rong-San Jiang; Hsin-Hua Chen
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

6.  Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice.

Authors:  Tamara Rusman; Saskia Ten Wolde; Sjoerd M Euser; Tjeerd van der Ploeg; Odile van Hall; Irene E van der Horst-Bruinsma
Journal:  Int J Rheum Dis       Date:  2018-04       Impact factor: 2.454

7.  Protective effect of anthrax toxin receptor 2 polymorphism rs4333130 against the risk of ankylosing spondylitis.

Authors:  Haitao Xu; Yiming Qu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

8.  Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany.

Authors:  Klaus Krüger; Gerd R Burmester; Siegfried Wassenberg; Martin Bohl-Bühler; Matthias H Thomas
Journal:  BMJ Open       Date:  2018-06-14       Impact factor: 2.692

9.  The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study.

Authors:  Bindee Kuriya; Simone Vigod; Jin Luo; Jessica Widdifield; Nigil Haroon
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

Review 10.  Efficacy and Safety of Sinomenine Preparation for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Randomized Controlled Trials.

Authors:  Shan-Shan Lin; Chun-Xiang Liu; Jun-Hua Zhang; Hui Wang; Jing-Bo Zhai; Jing-Yuan Mao; Xian-Liang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-14       Impact factor: 2.650

View more
  1 in total

Review 1.  Emerging Roles of Long Non-Coding RNAs in Ankylosing Spondylitis.

Authors:  Ruifu Sun; Xuesong Wang; Xiaohong Sun; Bing Zhao; Xiugong Zhang; Xiaojin Gong; Sunny Hei Wong; Matthew Tak Vai Chan; William Ka Kei Wu
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.